| Angelena Wells, MS | |
|
240 N Bluff Blvd, Clinton, IA 52732-7160 | |
| (319) 409-6922 | |
| Not Available |
| Full Name | Angelena Wells |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 240 N Bluff Blvd, Clinton, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235916099 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angelena Wells, MS 240 N Bluff Blvd, Clinton, IA 52732-7160 Ph: () - | Angelena Wells, MS 240 N Bluff Blvd, Clinton, IA 52732-7160 Ph: (319) 409-6922 |
News Archive
"If we needed more evidence that the funding cuts at the Global Fund to Fight AIDS, Tuberculosis and Malaria were going to be detrimental to people's lives, a new study ... makes it clear: Providing funding to fight malaria makes malaria go away," Kolleen Bouchane, director of ACTION, a global partnership of health advocacy organizations, writes in the Huffington Post's "Impact" blog.
The National Institutes of Health has awarded a prestigious EUREKA award to Robert Woods, a professor at the University of Georgia Complex Carbohydrate Research Center, to develop a new method for understanding how antibodies interact with large molecules known as glycans that are a major component of all cell surfaces.
Emergent BioSolutions Inc. announced today that its Investigational New Drug (IND) application, to commence a Phase I clinical trial for its anthrax monoclonal antibody therapeutic, has cleared U.S. Food and Drug Administration (FDA) review. The Phase I study will evaluate the safety and pharmacokinetics of the company's fully human monoclonal antibody being developed as a parenteral post-exposure therapy for individuals who have symptoms of anthrax disease. In pre-clinical therapeutic studies, Emergent's monoclonal antibody was found to be effective.
Bristol-Myers Squibb Company today announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understanding of immuno-oncology. Immuno-oncology focuses on the potential of harnessing the intelligence of the body's own immune system to fight cancer.
› Verified 1 days ago
Mr. Jill Sidlinger, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1320 11th St Nw, Ste A, Clinton, IA 52732 Phone: 563-243-4490 Fax: 563-243-4585 | |
Cassidy Amber Potter, Counselor Medicare: Not Enrolled in Medicare Practice Location: 240 N Bluff Blvd Ste 206, Clinton, IA 52732 Phone: 815-590-3707 | |
Mrs. Janice Lee Mussmann, MSC LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1320 11th St Nw, Ste A, Clinton, IA 52732 Phone: 563-243-4490 Fax: 563-243-4585 | |
Jada Mathison, Counselor Medicare: Not Enrolled in Medicare Practice Location: 927 N 2nd St Ste B, Clinton, IA 52732 Phone: 319-409-6922 | |
Maribeth Bousman, BA, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2219 Garfield St, Clinton, IA 52732 Phone: 563-242-6805 | |
Kelly Jean Saul, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 250 20th Ave N, Clinton, IA 52732 Phone: 563-243-2124 Fax: 563-243-2190 |